Abstract: A method is provided for synthesizing bio-based LPG from renewable sources via a bio-based synthetic gas feedstock, in a dual-stage reaction system comprising an oxygenate synthesis reaction zone and an oxygenate conversion reaction zone that are configured for producing and converting a methanol intermediate for reduced CO2 selectivity. The method includes recovering LPG from either the full reaction zone effluent or from a purge stream separated from the full reaction zone effluent for LPG recovery.

Abstract: A method is provided for synthesizing bio-based LPG from renewable sources via a bio-based synthetic gas feedstock, in a dual-stage reaction system comprising an oxygenate synthesis reaction zone and an oxygenate conversion reaction zone that are configured for producing and converting a methanol intermediate for reduced CO2 selectivity. The method includes recovering LPG from either the full reaction zone effluent or from a purge stream separated from the full reaction zone effluent for LPG recovery.

Abstract: A method is provided for synthesizing bio-based LPG from renewable sources via a bio-based synthetic gas feedstock, using a solvent absorption process and a solid adsorption process for recovering LPG in high yield while providing for high recovery and reuse, with low pressure drop, of unreacted synthesis gas components.

Abstract: Methods and pharmaceutical compositions for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) and the treatment of cancer are described.

Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.

Abstract: The present disclosure provides a polymer composition. In an embodiment, an ethylene-based polymer composition is provided and is formed by high pressure (greater than or equal to 100 MPa), free-radical polymerization, by reacting: ethylene monomer and a mixture of hydrocarbon-based molecules, with each hydrocarbon-based molecule comprising three or more terminal alkene groups.

Abstract: Extracorporeal blood treatment systems and methods to display graphical user interfaces displaying a plurality of fluids areas, each including a flow rate, and displaying adjustment notifications proximate one or more fluid areas. For example, when a user adjusts a flow rate to a limit, one or more notifications may be displayed proximate other flow rates that may be adjusted to modify the limit.

Abstract: A catheter for use in a system for forming a fistula between two vessels. The catheter comprises a catheter shaft, and a split backstop coupled to the catheter shaft and configured to receive a fistula-forming electrode. The split backstop has a proximal section and a distal section. The proximal section and the distal section are moveable relative to each other.

Abstract: A system for forming a fistula between two vessels. The system comprises a first catheter comprising a housing with an opening, and an electrode disposed at least partially within the housing. The electrode comprises a distal portion, a proximal portion and an intermediate portion therebetween for contacting a vessel wall and forming the fistula. The first catheter is configured to provide resistance against lateral movement of the intermediate portion, for example, through a spring, a push element, a guide element or a pull wire.

Abstract: Embodiments can relate to a system for generating a simulated dataset related to network activity. The system can include a processor and a memory including a data receiver module and a data synthesizer module. The memory can include instructions stored thereon that when executed by the processor will cause the processor to: execute the data receiver module to receive data including time ordered data and non-time ordered data; execute the data synthesizer module by implementing one or more machine learning models to generate synthetic data from received data. The one or more machine learning models can include a trained dataset trained with time ordered data and non-time ordered data. The data synthesizer can be configured to iteratively update the synthetic data until the synthetic data meets a threshold representative of network activity.

Abstract: Provided herein are methods of generating antigen-specific T cells for therapeutic administration to a human patient having or suspected of having a pathogen or cancer, utilizing soluble IL-15/IL-15R? complexes ex vivo, in cell culture during ex vivo sensitizing of T cells to the antigen or during ex vivo culturing of antigen-specific T cells. Also disclosed are antigen-specific T cells generated by such methods, and methods of treating a human patient using such antigen-specific T cells. Cell culture systems comprising human T cells, antigen-presenting cells, and soluble IL-15/IL-15R? complexes are also provided.

Abstract: A computer system automatically tests a network communication model by predicting whether particular traffic (whether actual or simulated) should be allowed on the network, and then estimating the accuracy of the network communication model based on the prediction. Such an estimate may be generated even before the model has been applied to traffic on the network. For example, steps can include observing positive data associated with a network; generating a network communication model based on the positive data; generating negative data based on the network communication model; calculating a precision of the network communication model based on the network communication model and the negative data; and calculating an accuracy of the network communication model based on one or more of the precision of the network communication model, or the network communication model and the positive data.

Abstract: A magnetic sensor package comprising a magnetic multi-turn sensor die and a magnetic single turn sensor die, in which both sensor dies are packaged on the same lead frame. A method of manufacturing the magnetic sensor package is also provided. A magnetic sensor system comprising a rotating magnet and the magnetic sensor package, where the sensor package is arranged so that both sensor dies sit within a homogenous magnetic field, thereby ensuring that the output signal of each sensor is not corrupted by any stray fields.

Abstract: A scrubber and methods of forming a scrubber. The scrubber may include a foamed melamine resin, a first foamed polyurethane resin, a second foamed polyurethane resin, and a binder. The scrubber can be configured to exhibit the properties of both a scrubber and an eraser, and have a density ranging from 0.01 to 0.5 grams per cm3. A method of forming the scrubber may include the following steps: mixing foamed melamine resin particles, first foamed polyurethane resin particles, and second foamed polyurethane resin particles to form a first mixture; and mixing the first mixture with a binder to form a second mixture.

Abstract: A telecommunications system is disclosed that coordinates and executes complex communication tasks using structured messaging and off-line synchronization.

Abstract: The present disclosure relates to the field of malodour counteraction. More particularly, it concerns the use of volatile compositions to limit, decrease or eliminate the perception of fecal malodour. Such compositions include a malodour antagonist system associated with perfuming ingredients performing as malodour counteractant, in a combination that significantly reduces the perception of fecal malodour. Such compositions, their use in combination with delivery systems and their applications in consumer products are objects of the present disclosure.

Abstract: A glare source device, a glare test system and methods that assesses visual performance and discomfort under varying levels of glare under varying lighting conditions is provided.

Abstract: The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.

Abstract: Extracorporeal blood treatment systems and methods to display status information for one or more fluids used in extracorporeal blood treatments. For example, a graphical user interface may include a fluids region depicting one or more fluid areas. Each fluid area may include pump and reservoir elements that depict flow rate information, reservoir volume information, and/or a notification related thereto.